SÜT DİŞİ AMPUTASYON TEDAVİSİNDE GÜNCEL YAKLAŞIMLAR

Year 2020, Volume: 30 Issue: 3, 528 - 535, 15.07.2020

Necibe Damla Şahin Volkan Arıkan

https://doi.org/10.17567/ataunidfd.640485

Abstract

Günümüzde doğal dentisyonu korumanın öneminin anlaşılmasına ve koruyucu diş
hekimliğine gösterilen ilginin artmasına rağmen, pek çok süt ve daimi diş çürük
nedeniyle erken kaybedilmektedir. Bu nedenle, düşme zamanlarına kadar
fonksiyonlarını devam ettirebilmeleri ve daimi dişlenmeye rehberlik etmelerini
sağlamak amacıyla, derin çürük nedeniyle pulpası etkilenmiş süt dişlerinin de
tedavi planlaması içinde bulunması gerekmektedir. Amputasyon tedavisi,
kısmen veya total olarak enfekte kuronal diş pulpasının çıkarılıp normal
yapıdaki kök pulpasının etkili ve bakterisit bir madde ile korunmasıyla
fonksiyonun sürdürülmesi işlemi olarak tanımlanmaktadır. Bu derlemede, çocuk
diş hekimliğinde uygulanan süt dişi amputasyon tedavileri için güncel tedavi
yöntem ve materyalleri hakkında literatürdeki yeni gelişmelerin sunulması
amaçlanmıştır.

Anahtar
Kelimeler: Amputasyon, süt dişi, çürük, diş pulpası

NEW APPROACHES IN PRIMARY TOOTH PULPOTOMY TREATMENT

ABSTRACT

Nowadays, although the importance of preserving
natural dentition is well-known and the knowledge about preventive dentistry
has increased, many primary and permanent teeth can be lost early due to
caries. Therefore, to maintain their function until
their exfoliation time and to guide permanent dentition, pulpally involved primary
teeth due to deep caries should be included in the treatment planning.
Pulpotomy treatment is defined as the process of maintaining function by
effective and bactericidal preservation of the healthy radicular pulp following
removal of partially or totally infected coronal pulp. In this review, it was
aimed to present the recent developments in the literature about the current
treatment methods and materials for the treatment of primary tooth pulpotomy in
pediatric dentistry.

Keywords:
Pulpotomy, primary teeth, caries, dental pulp

Keywords

Amputasyon, süt dişi, çürük

References

• 1. Tziafas D. The future role of a molecular approach to pulp-dentinal regeneration. Caries Res 2004;38:314-20.
• 2. Fuks AB. Pulp therapy for the primary and young permanent dentitions. Dent Clin North Am 2000;44:571-96.
• 3. Cohenca N, Paranjpe A, Berg J. Vital pulp therapy. Dent Clin North Am 2013;57:59-73.
• 4. Ranly DM. Pulpotomy therapy in primary teeth: new modalities for old rationales. Pediatr Dent 1994;16:403-9.
• 5. Fuks AB. Vital pulp therapy with new materials for primary teeth: new directions and Treatment perspectives. Pediatr Dent 2008;30:211-9.
• 6. Kahl J, Easton J, Johnson G, Zuk J, Wilson S, Galinkin J. Formocresol blood levels in children receiving dental treatment under general anesthesia. Pediatr Dent 2008;30:393-9.
• 7. Torabinejad M, Watson TF, Pitt Ford TR. Sealing ability of a mineral trioxide aggregate when used as a root end filling material. J Endod 1993;19:591-5.
• 8. Şen E, Çetiner S. Mİneral trioxide aggregate: Lİteratür derlemesİ. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi 2006;16:46-53.
• 9. Parirokh M, Torabinejad M. Mineral trioxide aggregate: a comprehensive literature review—part I: chemical, physical, and antibacterial properties. J Endod 2010;36:16-27.
• 10. Ferracane JL, Cooper PR, Smith AJ. Can interaction of materials with the dentin-pulp complex contribute to dentin regeneration? Odontology 2010;98:2-14.
• 11. Godhi B, Tyagi R. Success Rate of MTA Pulpotomy on Vital Pulp of Primary Molars: A 3-Year Observational Study. Int J Clin Pediatr Dent 2016;9:222-7.
• 12. Maroto M, Barberia E, Vera V, Garcia-Godoy F. Mineral trioxide aggregate as pulp dressing agent in pulpotomy treatment of primary molars: 42-month clinical study. Am J Dent 2007;20:283-6.
• 13. Goyal P, Pandit IK, Gugnani N, Gupta M, Goel R, Gambhir RS. Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. Eur J Dent 2016;10:315-20.
• 14. Witherspoon DE, Small JC, Harris GZ. Mineral trioxide aggregate pulpotomies: a case series outcomes assessment. J Am Dent Assoc 2006;137:610-8.
• 15. Asgary S, Shahabi S, Jafarzadeh T, Amini S, Kheirieh S. The properties of a new endodontic material. J Endod 2008;34:990-3.
• 16. Asgary S, Eghbal MJ, Parirokh M. Sealing ability of a novel endodontic cement as a root-end filling material. J Biomed Mater Res A 2008;87:706-9.
• 17. Ghorbani Z, Kheirieh S, Shadman B, Eghbal MJ, Asgary S. Microleakage of CEM cement in two different media. Iran Endod J 2009;4:87-90.
• 18. Asgary S, Eghbal MJ, Parirokh M, Ghanavati F, Rahimi H. A comparative study of histologic response to different pulp capping materials and a novel endodontic cement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:609-14.
• 19. Tabarsi B, Parirokh M, Eghbal MJ, Haghdoost AA, Torabzadeh H, Asgary S. A comparative study of dental pulp response to several pulpotomy agents. Int Endod J 2010;43:565-71.
• 20. Malekafzali B, Shekarchi F, Asgary S. Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2-year randomised clinical trial. Eur J Paediatr Dent 2011;12:189-93.
• 21. Viola NV, Tanomaru Filho M, Cerri PS. MTA versus Portland cement: review of literature. RSBO (Online) 2011;8:446-52.
• 22. Steffen R, van Waes H. Understanding mineral trioxide aggregate/Portland-cement: a review of literature and background factors. Eur Arch Paediatr Dent 2009;10:93-7.
• 23. Estrela C, Bammann LL, Estrela CR, Silva RS, Pecora JD. Antimicrobial and chemical study of MTA, Portland cement, calcium hydroxide paste, Sealapex and Dycal. Braz Dent J 2000;11:3-9.
• 24. Sakai VT, Moretti AB, Oliveira TM, Fornetti AP, Santos CF, Machado MA, Abdo RC. Pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. Br Dent J 2009;207:128-9.
• 25. Oliveira TM, Moretti AB, Sakai VT, Lourenco Neto N, Santos CF, Machado MA, Abdo RC. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. Eur Arch Paediatr Dent 2013;14:65-71.
• 26. Chang SW, Lee SY, Kum KY, Kim EC. Effects of ProRoot MTA, Bioaggregate, and Micromega MTA on odontoblastic differentiation in human dental pulp cells. J Endod 2014;40:113-8.
• 27. Grewal N, Salhan R, Kaur N, Patel HB. Comparative evaluation of calcium silicate-based dentin substitute Biodentine and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemp Clin Dent 2016;7:457-63.
• 28. Togaru H, Muppa R, Srinivas N, Naveen K, Reddy VK, Rebecca VC. Clinical and Radiographic Evaluation of Success of Two commercially Available Pulpotomy Agents in Primary Teeth: An in vivo Study. J Contemp Dent Pract 2016;17:557-63.
• 29. Cuadros-Fernandez C, Lorente Rodriguez AI, Saez-Martinez S, Garcia-Binimelis J, About I, Mercade M. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clin Oral Investig 2016;20:1639-45.
• 30. Celik BN, Mutluay MS, Arikan V, Sari S. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth. Clin Oral Investig 2019;23:661-6.
• 31. Ghoddusi J, Forghani M, Parisay I. New Approaches in Vital Pulp Therapy in Permanent Teeth. Iranian Endodontic Journal 2014;9:15-22.
• 32. Nakamura Y, Hammarstrom L, Matsumoto K, Lyngstadaas SP. The induction of reparative dentine by enamel proteins. Int Endod J 2002;35:407-17.
• 33. Ishizaki NT, Matsumoto K, Kimura Y, Wang X, Yamashita A. Histopathological study of dental pulp tissue capped with enamel matrix derivative. J Endod 2003;29:176-9.
• 34. Sabbarini J, Mohamed A, Wahba N, El-Meligy O, Dean J. Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. J Endod 2008;34:284-7.
• 35. Yildirim C, Basak F, Akgun OM, Polat GG, Altun C. Clinical and Radiographic Evaluation of the Effectiveness of Formocresol, Mineral Trioxide Aggregate, Portland Cement, and Enamel Matrix Derivative in Primary Teeth Pulpotomies: A Two Year Follow-Up. J Clin Pediatr Dent 2016;40:14-20.
• 36. El-Meligy O, Abdalla M, El-Baraway S, El-Tekya M, Dean JA. Histological evaluation of electrosurgery and formocresol pulpotomy techniques in primary teeth in dogs. J Clin Pediatr Dent 2001;26:81-5.
• 37. Sinha UK, Gallagher LA. Effects of steel scalpel, ultrasonic scalpel, CO2 laser, and monopolar and bipolar electrosurgery on wound healing in guinea pig oral mucosa. The Laryngoscope 2003;113:228-36.
• 38. Bahrololoomi Z, Moeintaghavi A, Emtiazi M, Hosseini G. Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: a randomized clinical trial. Indian J Dent Res 2008;19:219-23.
• 39. Rivera N, Reyes E, Mazzaoui S, Moron A. Pulpal therapy for primary teeth: formocresol vs electrosurgery: a clinical study. J Dent Child 2003;70:71-3.
• 40. Dean JA, Mack RB, Fulkerson BT, Sanders BJ. Comparison of electrosurgical and formocresol pulpotomy procedures in children. Int J Paediatr Dent 2002;12:177-82.
• 41. Farrokh Gisoure E. Comparison of three pulpotomy agents in primary molars: a randomised clinical trial. Iran Endod J 2011;6:11-4.
• 42. Stringhini Junior E, Vitcel ME, Oliveira LB. Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol. Eur Arch Paediatr Dent 2015;16:303-12.
• 43. Coluzzi DJ. Fundamentals of dental lasers: science and instruments. Dent Clin North Am 2004;48:751-70.
• 44. Ulusoy AT, Bayrak S, Bodrumlu EH. Clinical and radiological evaluation of calcium sulfate as direct pulp capping material in primary teeth. Eur J Paediatr Dent 2014;15:127-31.
• 45. Güngörmüş M, Ömezli MM. Diş hekİmlİğİnde lazer kullanimi sirasinda oluşabİlecek zararlar ve alinacak önlemler. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi 2007;2007:31-3.
• 46. Gençay K. Pedodontİ'de nd. Yag lazer kullaniminin İncelenmesi (olgu bildirimi). Journal of Istanbul University Faculty of Dentistry 1994;28:91-6.
• 47. Jayawardena JA, Kato J, Moriya K, Takagi Y. Pulpal response to exposure with Er:YAG laser. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:222-9.
• 48. Niranjani K, Prasad MG, Vasa AA, Divya G, Thakur MS, Saujanya K. Clinical Evaluation of Success of Primary Teeth Pulpotomy Using Mineral Trioxide Aggregate(R), Laser and Biodentine(TM)- an In Vivo Study. J Clin Diagn Res 2015;9:35-7.
• 49. Durmus B, Tanboga I. In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomed Laser Surg 2014;32:289-95.
• 50. Yadav P, Indushekar KR, Saraf BG, Sheoran N, Sardana D. Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an “in-vivo” study. Laser Therapy 2014;23:41-7.
• 51. Goker H, Haznedaroglu I, Ercetin S, Kirazli S, Akman U, Ozturk Y, Firat H. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper®. Journal of International Medical Research 2008;36:163-70.
• 52. Odabas ME, Cinar C, Tulunoglu O, Isik B. A new haemostatic agent's effect on the success of calcium hydroxide pulpotomy in primary molars. Pediatr Dent 2011;33:529-34.
• 53. Yaman E, Gorken F, Pinar Erdem A, Sepet E, Aytepe Z. Effects of folk medicinal plant extract Ankaferd Blood Stopper((R)) in vital primary molar pulpotomy. Eur Arch Paediatr Dent 2012;13:197-202.
• 54. Cantekin K, Gumus H. Success Rates of Ankaferd Blood Stopper and Ferric Sulfate as Pulpotomy Agents in Primary Molars. Int Sch Res Notices 2014;2014:819605.
• 55. Ozmen B, Bayrak S. Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Niger J Clin Pract 2017;20:832-8.
• 56. Cerqueira DF, Mello-Moura AC, Santos EM, Guedes-Pinto AC. Cytotoxicity, histopathological, microbiological and clinical aspects of an endodontic iodoform-based paste used in pediatric dentistry: a review. J Clin Pediatr Dent 2008;32:105-10.
• 57. Boeve C, Dermaut L. Formocresol pulpotomy in primary molars: a long-term radiographic evaluation. ASDC J Dent Child 1982;49:191-6.
• 58. Rajasekharan S, Martens LC, Vandenbulcke J, Jacquet W, Bottenberg P, Cauwels RG. Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. Int Endod J 2017;50:215-28.
• 59. Laurent P, Camps J, About I. Biodentine(TM) induces TGF-beta1 release from human pulp cells and early dental pulp mineralization. Int Endod J 2012;45:439-48.
• 60. Jasprica I, Bojic M, Mornar A, Besic E, Bucan K, Medic-Saric M. Evaluation of antioxidative activity of Croatian propolis samples using DPPH* and ABTS*+ stable free radical assays. Molecules 2007;12:1006-21.
• 61. Cuesta A, Rodríguez A, Esteban MA, Meseguer J. In vivo effects of propolis, a honeybee product, on gilthead seabream innate immune responses. Fish & Shellfish Immunology 2005;18:71-80.
• 62. Shinmei Y, Yano H, Kagawa Y, Izawa K, Akagi M, Inoue T, Kamei C. Effect of Brazilian propolis on sneezing and nasal rubbing in experimental allergic rhinitis of mice. Immunopharmacol Immunotoxicol 2009;31:688-93.
• 63. Mani F, Damasceno HC, Novelli EL, Martins EA, Sforcin JM. Propolis: Effect of different concentrations, extracts and intake period on seric biochemical variables. J Ethnopharmacol 2006;105:95-8.
• 64. Al-Shaher A, Wallace J, Agarwal S, Bretz W, Baugh D. Effect of propolis on human fibroblasts from the pulp and periodontal ligament. J Endod 2004;30:359-61.
• 65. Kusum B, Rakesh K, Richa K. Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry & Endodontics 2015;40:276-85.
• 66. Tsao S-M, Yin M-C. In-vitro antimicrobial activity of four diallyl sulphides occurring naturally in garlic and Chinese leek oils. Journal of medical microbiology 2001;50:646-9.
• 67. Martin KW, Ernst E. Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. Journal of Antimicrobial Chemotherapy 2003;51:241-6.
• 68. Fani M, Kohanteb J, Dayaghi M. Inhibitory activity of garlic (Allium sativum) extract on multidrug-resistant Streptococcus mutans. Journal of Indian Society of Pedodontics and Preventive Dentistry 2007;25:164.
• 69. Akan S. Sarımsak (allium sativum l.) tüketiminin insan sağlığına yararları. Academic Food Journal 2014;12:95-100.
• 70. Mohammad SG, Raheel SA, Baroudi K. Clinical and Radiographic Evaluation of Allium sativum Oil as a New Medicament for Vital Pulp Treatment of Primary Teeth. Journal of International Oral Health : JIOH 2014;6:32-6.
• 71. Purohit RN, Bhatt M, Purohit K, Acharya J, Kumar R, Garg R. Clinical and radiological evaluation of turmeric powder as a pulpotomy medicament in primary teeth: An in vivo study. International Journal of Clinical Pediatric Dentistry 2017;10:37-40.
• 72. Karaman BE, Köseler E. Zerdeçalın kronik hastalıklarla İlişkisi. Başkent Üniversitesi Sağlık Bilimleri Fakültesi Dergisi-BÜSBİD 2017;2:96-112.
• 73. Hugar SM, Kukreja P, Hugar SS, Gokhale N, Assudani H. Comparative Evaluation of Clinical and Radiographic Success of Formocresol, Propolis, Turmeric Gel, and Calcium Hydroxide on Pulpotomized Primary Molars: A Preliminary Study. Int J Clin Pediatr Dent 2017;10:18-23.
• 74. Shah SS. Aloe Vera: The Herbal Panacea in Dentistry. International Journal 2014;1:25.
• 75. Sujatha G, Kumar GS, Muruganandan J, Prasad TS. Aloe vera in dentistry. J Clin Diagn Res 2014;8:ZI01-ZI2.
• 76. Gupta N, Bhat M, Devi P, Girish. Aloe-Vera: A Nature’s Gift to Children. International Journal of Clinical Pediatric Dentistry 2010;3:87-92.
• 77. Kalra M, Garg N, Rallan M, Pathivada L, Yeluri R. Comparative Evaluation of Fresh Aloe barbadensis Plant Extract and Mineral Trioxide Aggregate as Pulpotomy Agents in Primary Molars: A 12-month Follow-up Study. Contemp Clin Dent 2017;8:106-11